PD-L1 Biomarker Testing Market SWOT Analysis, by Key Players

As the prevalence of lung cancer, melanoma, and renal cell carcinoma continues to soar worldwide, the adoption of PD-L1 biomarker testing is expected to grow at a healthy pace in the years to come, says Future Market Insights (FMI) in its new market study. Moreover, the report forecasts that the global PD-L1 biomarker testing market will grow in value at a stellar CAGR of 13.1% between 2020 and 2030.

The report opines that the outbreak of COVID-19 is likely to create short-term fluctuations on the supply side due to pandemic-related issues such as workforce shortages and disruptions of delivery networks. Similarly, a steep decline in the number of tests has been observed during the pandemic, and this is expected to further decelerate the demand for PD-L1 biomarker testing.

The report primarily attributes the growth of the market to the increasing incidence of cancers, especially lung and skin, coupled with the development of advanced diagnostic kits and assays.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Likewise, rising awareness regarding the availability of testing methodology such as immunohistochemistry-based assays and Enzyme-linked Immunoassay (ELISA) based detection will continue to impel the adoption of PD-L1 biomarkers in the forthcoming years.

Key Takeaways

  • The global PD-L1 biomarkers testing market is expected to surge past valuation of US$ 2.05 Bn by the end of the forecast period.
  • PD-L1 SP142 assay kits will remain the most popular products among end-users, capturing nearly half of the market value, owing to high efficiency in detecting cancer tumors.
  • Non-small cell lung cancer and melanoma are cumulatively expected to hold more than 50% of the total market value on the back of the soaring prevalence of these diseases.
  • By end-use, PD-lL1 biomarker testing finds the majority of applications in hospitals, which is expected to account for over 60% of market value.
  • North America will spearhead the regional landscape through the forecast period, accounting for more than 50% of the global market value.
  • Europe is poised to remain the second most lucrative region, holding nearly 1/3rd of market value.

“Market players are directing their efforts towards improving the accessibility of these products and are marking them cost-effective to ensure wide-scale adoption,” remarks FMI analyst.

COVID-19 Impact on PD-L1 Biomarker Testing Market

The COVID-19 pandemic has created disruptions across the healthcare technology landscape and has resulted in a shifting preference among manufacturers towards essential technologies and treatments. Furthermore, although PD-L1 biomarker testing is used to test severe diseases such as cancer, a reduced number of screenings is adversely impacting the demand for testing.

For instance, according to trends observed by Cancer Research Network, screening rates of melanoma plummeted by approximately 50% in the UK in the past few months. Likewise, in the US, the number of tests conducted to detect non-small cell lung cancer fell by 30% in March as compared to February. As patients reschedule or skip regular screenings, this is creating a downtrend in demand for PL-D1 biomarker testing.

However, considering the severity of these diseases, the need for testing will swiftly arise in the future, ensuring that the market’s growth trajectory remains intact.

Who is Winning?

Key players operating in the market are focusing on enhancing existing product designs and developing novel products with increased accuracy. Moreover, traditional growth strategies such as acquisitions and mergers have been identified as strategies adopted by players to strengthen their foothold in the competitive landscape.

  • In January 2019, Abcam Plc acquired Calico Biolabs with an objective to expand its custom monoclonal production service capabilities.
  • In December 2018, NeoGenomics, Inc. acquired Genoptix, Inc. to improve its oncology diagnostic services.

FMI’s report includes profiles of some of the most prominent names in the market including F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., NeoGenomics Laboratories, Inc, HalioDx and Abcam plc. among others.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5897

To Know More About PD-L1 Biomarkers Market

A new market research report published by Future Market Insights (FMI) on the global PD-L1 biomarkers market offers an executive-level blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – product, indication, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Natural Cosmetics Market Outlook, SWOT Analysis And Forecasts By 2027

According to a recently published business intelligence report by Future Market Insights (FMI), the global natural cosmetics market was valued at over US$ 36 Bn in 2019. Rising awareness about the side effects of chemical-based beauty products and the trend of ‘green beauty’ is encouraging manufacturers to increase the production of natural cosmetics to target and retain a large segment of consumers.

For more insights into the market, request a sample of this report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-8588

Tata’s Natural Alchemy, LLC and Henkel AG & Company, KGaA are amongst the top companies introducing all chemical-free products in their portfolio, as consumers’ inclination towards cosmetics with natural, safer ingredients intensifies.

Key Takeaways – Natural Cosmetics Market Study 

  • In comparison with demand in commercial spaces such as salons & spa, household consumption of natural cosmetics remain on the higher side. Adoption of natural cosmetics in households accounts for approximately 2/3rd of the market revenue.
  • As per the FMI’s study, hair care and skin care natural cosmetics account for more than 50% of the total sales. Growing demand for these traditional products with organic and plant-based ingredients is expected to complement the market growth.
  • In 2019, sales of unisex natural cosmetics held over 1/4th of the total revenue. On the contrary, natural cosmetics for men are expected to witness higher demand over the forecast period.
  • Sales of natural cosmetics through wholesalers or distributors continue to account for the high share of the global market value.
  • To strengthen their distribution network and increase consumer base, manufacturers are directing their sales towards convenience stores and hypermarkets/supermarkets.
  • Distribution via online stores is expected to gain tremendous popularity shortly.
Europe Captures Major Market Share

Over the forecast period, Europe will continue to hold a significant share in the global natural cosmetics market. European Union has set up a sophisticated legislative framework for players to enter the natural cosmetics market. It assures that products sold in the EU market should fulfill the required standards.

In addition, European consumers widely prefer natural and plant-based products as the region supports sustainability, which, in turn, is fueling the market growth. Demand will remain concentrated in Germany, Spain, France, Italy, and the UK and the presence of a larger distribution network with various sales channels will continue to attract new consumers.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-8588

More Valuable Insights

FMI’s report on the natural cosmetics market is segmented into five major sections-

Product

  • Skincare
  • Haircare
  • Fragrance
  • Toiletries
Application
  • Male
  • Female
  • Unisex
  • Baby
End-use
  • Personal care
  • Salon & spa
Sales Region
  • Hypermarket/Supermarket
  • Online Stores
  • Convenience Stores
  • Specialty Stores
  • Wholesale/Distributors
  • Club Stores

And region to help readers understand and evaluate lucrative opportunities in the global natural cosmetics market.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-8588

Natural Cosmetics for Male Consumers to Gain Traction in Future

Modern men are taking a keen interest in caring for their skin. A rising number of men are inclining towards personal grooming and boosting greater self-confidence by looking good. In recent times, men are no longer limiting themselves to only shaving products and deodorants and becoming habitual users of skin and personal care products.

The organic and vegan beauty movement is also playing an important role in building a male consumer base. Additionally, chemical-free skincare products are finding greater resonance among young men who choose to align themselves with renowned brands. This, in turn, is expected to fuel the demand for natural cosmetics for male consumers.

Optical Coherence Tomography Market Trends, Business Outlook 2020, Expanding Current Industry Status by Top Most Players 2031

ESOMAR-certified consulting firm Future Market Insights’ report, projects a healthy growth, for optical coherence tomography (OCT) market. As per the report, the market is forecast to reach a valuation of US$ 1349.09 Mn over the forecast period of 2021 and 2031.

Growing application of OCT in ophthalmology across China, the U.K., Germany and Japan will bolster the demand of optical coherence tomography across the globe.

As per the FMI’s analysis, the optical coherence tomography market across Japan and China is anticipated to expand at over 9.8% and 4.6%, respectively in 2021. Growing prevalence of eye related disorders such as diabetic retinopathy, glaucoma and others will improve the adoption of OCT imaging systems.

Development of advanced OCT imaging systems coupled with increasing government & private organizations initiatives for eye care programs across the globe are propelling the adoption of OCT imaging systems.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3362

Growing awareness and increasing innovation for the advanced OCT devices for the treatment of skin cancer and eye diseases have urged the manufacturers to incorporate real-time data for better outcomes, expanding their existing product ranges.

Based on the aforementioned factors, the OCT market is slated to expand at a robust pace of over 6.7% CAGR during the assessment period of 2021 and 2031.

Key Takeaways from FMI’s Optical Coherence Tomography Market Study

  • Hospitals are anticipated emerge as primary end users of optical coherence tomography market, accounting for leading market share
  • Preference for spectral domain-OCT will be higher as compared to swept source-OCT over the forecast period
  • Increasing application of OCT in ophthalmology is expected to drive sales through 2031
  • Germany and the U.K. will lead the Europe’s optical coherence tomography market on the back of rising cases of eye disorders across the region
  • Japan is anticipated to emerge as a lucrative market backed by the rising development of advanced OCT imaging systems within healthcare sector
  • China is anticipated to lead the East Asia market during the forecast period, accounting for over 4.6% market sales
  • The U.S. is estimated to be the largest market for optical coherence tomography market attributed to be growing prevalence of eye related disorders

“Key players are increasing research and development activities for the development of advanced OCT imaging system for the early detection & treatment of eye-related disorders. This, in turn, is likely to omprovegrowth opportunities for the market players over the coming years,” says the FMI analyst. 

Optical Coherence Tomography Market Competitive Landscape

Future Market Insights, in its updated report, have profiled prominent players operating in optical coherence tomography market which include Leica Microsystems, Optovue Inc., Carl Zeiss Meditec AG, Santec Corporation, Heidelberg Engineering GmbH, Optopol Technology SP Z.O.O., Topcon Corporation, Michelson Diagnostic Ltd., Tomophase Inc., Moptim Imaging Technique, NIDEK Co. Ltd., and Sonostar Technologies Co. Ltd among others.

Optical coherence tomography systems manufacturers are actively focusing on expanding their product portfolios to improve their revenue generation.

Incorporation of advanced technology combined with the upgradation of its existing range of products is also one of the core strategies of market players to maintain their position in the industry.

The global optical coherence tomography market is dominated by top tier-1 market players that include Leica Microsystem (Sub. Danaher), Optovue Inc., and Zeiss Group (Carl Zeiss Meditec AG).

Targeted mergers and collaborations with top distribution channel partners is anticipated to be the key strategy to maintain their top position in the industry. Around 20% to 25% of global market revenue is contributed by the tier-1 players over the forecast period.

New product launches with the expansion of their existing product range is one of the common market strategy for the key players. For instance:

In March 2021, Premier Medical Imaging AI Inc., a medical technology company focusing to transform cancer surgery with ultra-high resolution, announced the 510 (k) clearance for its Perimeter’s Optical Coherence Tomography imaging system (v2.1) from the U.S. Food & Drug Administration (FDA), designed to examine tissue microstructures during surgical procedures.

In January 2021, Notal Vision announced the launch of its first ‘US Home-Based’ optical coherence tomography platform which was patient self-operated.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-3362

More Insights on the Global Optical Coherence Tomography Market

Future Market Insights, in its latest report, offers an incisive coverage on the global optical coherence tomography market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (spectral domain-OCT, swept source-OCT, and others), application type (ophthalmology, dermatology, cardiovascular, dental, and others), and end user (hospitals, ophthalmology clinics, dermatology clinics, dental clinics, ambulatory surgical centers, and others) across seven major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Direct Reduced Iron (DRI) Market expected to reach & ~ 7 % CAGR through 2021-2030

FMI, in its upcoming business report, elaborates the historical and current scenario of the Direct Reduced Iron (DRI) Market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions, and players on the basis of demand patterns and growth prospects.

Direct reduced iron (DRI) has recently emerged as a quality supplement, in place of scrap steel, among steel-making companies. Increasing steel production capacities heightened awareness about CO2 emission control among steel producers, and accelerating demand for high-quality steel from end-users continues to drive DRI consumption in the global market. According to a recent report published by Future Market Insights (FMI), the global DRI market is projected to reach revenues worth US$ 17 Bn by 2030 end, with growth projected at an impressive CAGR between 2020 and 2030.

dri market key countries and production process

While increasing steel production capacities in China, India and some Middle Eastern countries account for the amplifying DRI demand, the COVID-19 pandemic has led to disruptions across end-use industries, thereby impeding demand for steel. Ban on steel scrap imports is significantly steering sales of DRI amid the global coronavirus outbreak. Surplus supply, and low demand and high storage volumes will result in considerably falling steel production in the near term, ultimately affecting the demand for DRI. Pet dietary

Key Takeaways from DRI Market Study

The gas-based production process to remain as the go-to option among manufacturers, especially in North America, Europe, and the Middle East, due to lower natural gas prices

Coal-based production is dominated by India, which accounts for almost 80% of the DRI produced through a coal-based process

Pellets are the most preferred among DRI form types, as they are easy to transport, have better reactivity, and are cost-effective than lumps

Over the recent past, DRI imports have been witnessing a steady rise despite facing stern competition from hot briquetted iron (HBI); the latter has low reactivity and is subject to lower transportation costs

Vertical integration strategies adopted by steel manufacturers to produce DRI at their own facilities would remain an impending trend in the near future

DRI Market: Key Participant Insights

While DRI will not replace scrap steel as the primary raw material for steel production, it is projected to be utilized as a key ingredient and in higher proportions. In addition, the growing demand for high-quality steel products is further expected to drive DRI demand. Most of the leading tier-1 manufacturers in the DRI market, like ArcelorMittal, SIDOR, Jindal Steel, Mobarakeh Steel, and Nucor, use most of their production for captive consumption and the rest for exports to major steel manufacturers around the world. Capacity expansions are also one of the primary focuses of the globally leading manufacturers to stay ahead of the competition.

Direct Reduced Iron (DRI) Market: Segmentation

Production Process

  • Coal-based
  • Gas-based

Application

  • Steel Production
  • Construction

Form

  • Lumps
  • Pellets

Contact Sales for Further Assistance in Purchasing this Report@  https://www.futuremarketinsights.com/checkout/11635

Region

  • North America
  • Latin America
  • Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Leading Suppliers in DRI Market

While the DRI market landscape is currently controlled by a number of existing players, the near future is more likely to witness the emergence of new steel manufacturers that are currently investing in vertical integration of their businesses. Banking on the ability to satisfy their own demand, and backed by consistently falling raw material procurement costs, DRI manufacturers are witnessing promising growth avenues, especially in the Middle East. Some of the key players in the global DRI market include,

Americas

  • ArcelorMittal
  • Ferrominera Orinoco (FMO)
  • Venezolana de Prerreducidos Caroní C.A. (Venprecar)
  • NUCOR

Europe & Middle East

  • Mobarakeh Steel Company
  • Khouzestan Steel Company
  • Tosyal? Holding
  • METALLOINVEST MC LLC

Asia Pacific

  • JSW
  • AM/NS India
  • Tuwairqi Steel Mills

Global Femtech Market – Notable Developments, Upcoming Trends & Future Applications 2031

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Market demand is set to rise at a steady pace throughout the forecast period, majorly favoured by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.

The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11761

Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.

Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.

Key Takeaways from Femtech Market Study

  • Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
  • Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
  • The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
  • The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
  • China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.

“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst

Who is Winning?

Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.

Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.

  • Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
  • Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.

Key market players covered by FMI include Clue, Aparito Limited, Bloomlife, Bonzun Health Information AB, Elvie, Ava Science Inc., Grace Health, iBreve, LactApp, Natural Cycles Nordic AB, Hera Med Ltd., Niramai Health, NURX Inc., SteadySense GmbH, Pregnolia AG, Willow, WOOM and B-wom.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11761

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global femtech market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the femtech market based on service (diagnostics, monitoring, therapeutic), application (general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer and chronic disease), and end-user (direct-to-consumer, hospitals, surgical centres, fertility clinics, diagnostics centres) across seven major regions.

Light Therapy Market 2022 | Scope of Current and Future Industry 2031

ESOMAR certified market research company Future Market Insights (FMI) global light therapy market is likely to surpass US$ 1 billion in the short-run, expanding at a moderate CAGR in that time period. Long-term prospects appears largely optimistic, with credible opportunities expected to present themselves with respect to addressing acute depression problems.

As per FMI’s report, growth prospects are likely to emerge across skin and insomnia treatment domains as well. With at least one to three out of ten people experiencing disrupted sleep cycles, patients are seeking effective therapeutic approaches, thereby widening growth prospects. Furthermore, skin ailments contribute to almost 2% of the global burden of disorders.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1160

Manufacturers are primarily emphasizing on introducing portable and lightweight handheld light therapy devices amid the rising demand for flexible therapeutic solutions. For instance, the LightStim For Wrinkles is an award-winning FDA-cleared red light therapy device for skincare, deploying a patented multi-wave technology based on advanced LED technology from NASA. Likewise, the iRestore Laser Hair Growth System for treating androgenic alopecia deploys a 650 mm wavelength red light which is clinically proven to enhance hair growth.

light therapy market characteristics and attributes with regional relevence, 2021-2031

Key Takeaways from FMI’s Light Therapy Market Study

  • By product, handheld light therapy devices for skin treatment are likely to enjoy highest demand
  • By light type, demand for red light therapy is expected to reach new heights, characterized by increasing numbers of clinical trials
  • By end-user, dermatological centers are expected to be primary light therapy treatment centers in forthcoming years
  • High seasonal affective disorder (SAD) incidence fueling light therapy treatment in the US
  • UK to attract high investments, characterized by the presence of prominent phototherapy light manufacturers
  • Germany to generate lucrative growth prospects amid extensive applications across the photodynamic treatment (PDT) segment
  • Surging dermatological problems to widen natural treatment approaches scope in India, widening prospects for light therapy

Innovations by incorporating the latest light dissipating technologies while simultaneously ensuring minimal side effects forms the cornerstone of prominent manufacturers’ marketing strategy, generating credible growth opportunities, says the FMI analyst.

Competitive Landscape

Koninklijke Philips N.V., Verilux Inc., Northern Light Technology, Sphere Gadget Technologies, Zepter International, PhotoMedex Inc., Luminette, Klarstein, Lumie and Aura Daylight are some prominent light therapy market players profiled by FMI’s report on the landscape.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1160

Offering new products based on the latest technology is the primary strategy deployed by a majority of the aforementioned market players. For instance, Klarstein offers its 3MC light therapy sunlight SAD disorder lamp for medical purposes. This product is especially suitable for treating for treating seasonal affective disorder by deploying a mid-day simulating spectrum.

In September 2019, Lumie launched the Bodyclock Luxe 700FM and Bodyclock Luxe 750DAB wake up lights. These are class-I medical devices which offer high quality light and audio experience for easier sleep and brighter waking. These clocks are tuned to reflect day time patterns which helps regulate sleep to improve mood, energy, productivity and sleep quality.

How Historical & Future Outlook for Light Therapy Market Compare?

The global light therapy market has posted substantial gains in the past, majorly underpinned by increasing applications across a broad spectrum of healthcare applications. These typically range from treating a multitude of skin disorders to ensuring good psychological well-being of patients. Light therapy is widely popular for proving effective in addressing seasonal affective disorders, especially in the developed world.

More Insights on the Global Light Therapy Market

In its latest report, FMI offers an unbiased analysis of the global light therapy market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (light box, floor and desk lamps, light visor, dawn simulator, light therapy bulbs and handheld devices for skin treatment), light type (white light, blue light, red light and others) and end-user (dermatology clinics, homecare settings and others (workplace, salons)) across seven regions (North America, Latin America, APEJ, Western Europe, Eastern Europe, Middle East & Africa and Japan).

Light Therapy Market by Category

By Product

  • Light Box
  • Floor and Desk Lamps
  • Light Visor
  • Dawn Simulator
  • Light Therapy Bulbs

By Light Type

  • White Light
  • Blue Light
  • Red Light

By End User

  • Dermatology Clinics
  • Homecare Settings
  • Others (Workplace, Salons)

By Region

  • North America
  • Latin America
  • APEJ
  • Western Europe
  • Eastern Europe
  • Middle East & Africa
  • Japan

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/1160

Key Questions Answered in the Report

How will the light therapy market expand in 2021 and beyond?

Which prominent players operate within the global light therapy market?

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Foley Catheter Market Potential Growth, Share, Demand And Analysis Of Key Players- Analysis Forecasts To 2030

The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

  • The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
  • By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
  • Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
  • Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
  • North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
  • Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

“With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7769

Who is Winning?

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

  • C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
  • B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
  • In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

FMI’s report includes profiles of some of the most prominent names in the market including Teleflex Incorporated, Cardinal Health, C.R Bard, B. Braun Melsungen AG, Coloplast A/S, Medtronic plc, Flume, ConvaTec Group, VOTG Medical, Sterimed Group, Ribbel International Limited, Angiplast Private Limited, Mais India Medical Devices Private Limited, and JK Medirise.

Cold Laser Therapy Market 2022 Outlook, Current and Future Industry Landscape Analysis 2031

According to a recent study by Future Market Insights (FMI), the cold laser therapy market is expected to witness high growth during the forecast period. Sales of cold laser therapy are set to reach US$ 165.4 Mn by 2031. This reflects a CAGR of around 4.4% over the forecast period (2021-2031).

Increasing awareness about various benefits of cold laser therapy is encouraging the adoption of cold laser or low-level laser therapy devices. Application of cold laser therapy in pain relief, treatment of musculoskeletal conditions, and nerve regeneration is increasing the sales in the market. These devices are increasingly installed in home care settings to offer relief from pain or inflammation to patients.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3639

Due to increasing penetration of social media, people of all age groups are becoming overtly anxious about improving their appearance. Hence, the cold laser therapy market is rapidly growing owing to the growing interest in surgically improving appearance.

According to the World Health Organization (WHO), the global population of those above 65 years of age is expected to increase from nearly 1.0 billion in 2018 to around 2.1 billion by 2050 across the world.

cold laser therapy market characteristics and attributes with regional relevance 2021

With increasing demand from elder population as their skin is more prone to wrinkles, fine lines, flaccid skin, and other conditions, demand for cosmetic procedures is expected to surge.

Emerging nations such as India, China, Brazil, Russia, Mexico, and South Africa are offering ample of growth opportunities for cold laser therapy devices market. One of the major factor for increased growth is rising prevalence of chronic diseases in the countries.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3639

Exhibiting high demand for cold laser therapy to treat chronic pains, developing nations are likely to emerge as hotspot for cold laser therapy devices manufacturers.

Increasing research and development activities for innovation of novel technology and implementation of favorable reimbursement schemes in most developed countries is another factor fueling sales.

As per the report, key manufacturers are strengthening their supply chains particularly in regions such as Asia Pacific, Latin America and Middle East & Africa. Agreements, partnerships, and collaborations have emerged as key growth strategies adopted by leading players to expand their regional expansion and product portfolio.

For instance, in September, 2019, MedShift announced the 5-Year Strategic collaboration with BTL Aesthetics.  The partnership will boost the presence of Emsculpt® device, the first and only technology to non-invasively harness high-intensity electromagnetic energy to firm muscle for a more toned figure.

Key Takeaways from Cold Laser Therapy Market Study

  • In terms of product, continuous laser devices will account for the largest market share in 2021.
  • Single wavelength technology will hold the lion’s share in cold laser therapy market. The segment will account for more than 65% of total market share in 2021.
  • Application of cold laser therapy devices in dermatology will generate highest revenue. As per FMI, the application is expected to account for more than 35% of value share in 2021.
  • Specialty clinics are expected to be the primary end-users on the back on increasing demand for cold laser therapy for cosmetic procedures. The segment will contribute over 42% of market revenue in 2021.
  • North America is expected to account for dominant 40.0% in the global market in 2021, with the U.S. spearheading growth in the region.

 Growing demand for aesthetic cosmetic procedures and preference for non-invasive equipment have encouraged the key players to invest more in research activities to develop advanced devices. This is expected to create growth opportunities for market players, especially in East and South Asia as demand for cosmetic procedure and pain management is at all-time high, says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of cold laser therapy market are focusing on product launches,  collaborations, and expansion strategies to enhance their market presence. For instance,

  • In March 2021, Good Energies Ltd developed and sold the B-Cure Laser for pain relief and launched a new media campaign in collaboration with Guerillascope for creating awareness against chronic pain.
  • In November, 2020, DJO Global, Inc. announced the launch of 25W LightForce Xpi to allow clinicians to treat pain and inflammation and aid in post-activity recovery with greater accuracy, providing more consistent outcomes for patients.
  • In January 2020, BTL launched a new product BTL-6000 Traction Therapy for relieving patients from pain. The company strengthened its presence in the pain management market with this launch.
  • In May 2019, Theralase Technologies Inc. announced its plan to expand its photodynamic therapy technology (PDT) into China after receiving necessary regulatory approval from the country.
  • In May 2019, Erchonia Corporation announced the launch of Lunula Laser in the Korean market. It was a non-thermal and non-invasive device with low-level laser technology for foot fungus.
  • In January 2020, Lexington International, LLC announce the launch of its innovative product Flip 80 Laser Cap to treat pattern hair loss and stimulate hair growth

The key market players profiled by FMI include Apira Science Inc., BioLight Technologies LLC, B-Cure laser Australia, Erchonia Corporation, Theralase Inc., THOR Photomedicine Ltd, DJO Global, Inc., BTL, Spectro Analytic Irradia AB, Photomedex.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/3639

Key Questions Answered in the Report

What are the factors driving demand outlook of the global cold laser therapy market?

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Video Doorbell Market Outlook, Geographical Segmentation, Industry Size & Share, Analysis to 2027

Penetration of internet and transition towards digitalization have led to the introduction of various enhanced home consumer electronic devices such as DIY smart security solution, video intercoms, keyless entry systems and video doorbells.

A video doorbell is a device that enables the end-user to monitor who is at the door of his/her residence, on a screen of the system or on a smartphone/tablet, etc. (i.e. remotely). The product is comparatively new in the market which, therefore, offers an opportunity to various small and medium sized vendors to strengthen their presence in the market.
Various video doorbell vendors, for instance, are signing agreements with established players with an intention of expanding their business in the market. In February 2018, Amazon acquired Ring, a video doorbell manufacturer. Ring, with the help of this agreement, aims at increasing the sales of its video doorbells globally.

Video Doorbells are comparatively new in the market but are expected to witness a boom in the future, especially in developing countries such as India and China.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6951

Video Doorbell Market: Dynamics

A continuous demand for smart homes, smart appliances, etc. across developed and developing countries such as the U.S., China, India, Germany, Japan, and the U.K. has been witnessed. Factors such as enhanced security, remote accessibility, increased penetration of internet and demand for connected devices have furthermore proliferated the demand for this market. Accessibility of integrating various smart devices and enabling remote accessibility (from a smartphone/ tablet from distance) to offer enhanced security across various industry verticals is also a major driver for the video doorbell market.

However, issues such as network connectivity or network fluctuations hinder the efficient processing of the product and in turn hamper the growth of the video doorbell market. In context to this, lack of infrastructural development in developing countries (such as North African countries) also restraints the overall growth of the market.
One of the recent trends witnessed in the video doorbell market is increasing adoption of smart video doorbells (i.e. wireless connected video doorbells). Additionally, technological innovations have led to the integration of video doorbell systems with Alexa, Siri, etc. to enable the voice feature as well.

Attributing to the increasing penetration of internet and the trend witnessed in the adoption of smart home products, the e-commerce/online retailers segment is expected to account for a majority of sales in 2017. Furthermore, a higher preference for the same segment is expected during the forecast period.

Video Doorbell Market: Key Players

Some of the key players in the video doorbell market are August Home, Ring, dbell Inc., blink, Nest Labs, SkyBell Technologies, Inc., Olive & Dove (remo), Zmodo and smanos.

Of the above players, Ring, August Home and Nest Labs are expected to be the major revenue generating players in the video doorbell market.

Video Doorbell Market: Regional Overview

By geography, the video doorbell market can be segmented into North America, Latin America, Western Europe, Eastern Europe, China, Japan, SEA and others in Asia Pacific, and Middle East & Africa. Among these regions, North America is expected to dominate the global video doorbell market during the forecast period, owing to the presence of a high number of vendors and the high penetration of smart homes in the region. The U.S. is expected to hold a major share in North America video doorbell market, owing to the high demand for video doorbells from the residential industry to counter the increasing thefts and crime rates (across the same industry vertical). Europe is expected to follow North America in terms of revenue, while Asia Pacific (especially China and India) is expected to exhibit the highest growth rate owing to the increasing penetration of internet and the high demand for smart home appliances in the region.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Video Doorbell Market: Segmentation

The global video doorbell market can be segmented on the basis of product type, end-user, and sales channel.
On the basis of product type, the video doorbell market can be segmented as:

  • Standalone/Wireless Video Doorbells
  • Wired Video Doorbells

Standalone/Wireless video doorbells held a major share of the market in 2017 and the segment is expected to exhibit a higher growth rate during the forecast period as well.
On the basis of end-user, the video doorbell market can be segmented as:

  • Commercial
  • Industrial
  • Residential

On the basis of sales channel, the video doorbell market can be segmented as:

  • E-commerce/Online retailers
  • Organized retailers

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6951

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

PARP Inhibitors Market Set for Nearly 15% CAGR through 2026

Rising burden of various types of cancers such as ovarian, breast, prostate, and pancreatic cancer is anticipated to generate significant demand for PARP inhibitors. According to the Global Cancer Observatory (GLOBOCAN), countries such as China, the U.S., India, and Japan, collectively diagnose over 120,000 new cases of ovarian cancer each year. The incidence of breast cancer is much higher in these countries, and with superior efficacy of PARP inhibitors as compared to other available cancer treatment options, the PARP inhibitors market is expected to gain significant revenue over the forecast period.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3197

The global PARP inhibitors market is estimated to be valued at US$ 8.4 Bn by 2026, expanding at a significant CAGR from 2019 to 2026.

“The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period.”

Key Takeaways of PARP Inhibitors Market Study

  • Olaparib, with various expanded approvals for the treatment of ovarian cancer, breast cancer, and pancreatic cancer, and rapid increase in potential patient pool, contributed to the dominance of the segment by drug in 2018, and will continue to do so during the forecast period.
  • PARP inhibitors are regarded as a new standard of care for ovarian cancer after first-line platinum chemotherapy. Adoption of PARP inhibitors for ovarian cancer treatment has surged, and the trend is expected to continue during the forecast period, owing to the ability of PARP inhibitors to induce ovarian cancer patients into remission for longer periods of time as compared to any other marketed therapy.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-3197

  • With a strong pipeline, significant number of PARP inhibitors are expected to go for approval through the new drug application (NDA) process and for expanded approval to treat various types of cancers.

Strategic Acquisitions & Collaborations by Key Players to Widen Regional Presence

All marketed PARP inhibitors are under patent, and with no generic launch in sight till 2027, the market is expected to remain consolidated till the second half of this decade. Key players in the PARP inhibitors market are undergoing major collaborative efforts, mergers, and acquisitions in order to expand their regional product offerings. For example, in January 2019, GlaxoSmithKline plc acquired TESARO Inc., an oncology-focused biopharmaceutical company with a marketed PARP inhibitor named Zejula (Niraparib).

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-3197

North America and Europe would remain center stage, collectively accounting for a voluminous share of the PARP inhibitors market stack. Strong presence of technology natives as well as conducive reimbursement policies are critical in underpinning market growth in these developed regions.

In a bid to address the ever-increasing patient pool, governments in East and South Asia are upping per capita healthcare expenditure. This is influencing stakeholders to view these developing regions for value-creation opportunities.